Literature DB >> 12928240

High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2.

Shingo Yamada1, Keiichi Inoue, Keiko Yakabe, Hitoshi Imaizumi, Ikuro Maruyama.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928240     DOI: 10.1373/49.9.1535

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  29 in total

1.  High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy.

Authors:  Yoko Oyama; Teruto Hashiguchi; Noboru Taniguchi; Salunya Tancharoen; Tomonori Uchimura; Kamal K Biswas; Ko-Ichi Kawahara; Takao Nitanda; Yoshihisa Umekita; Martin Lotz; Ikuro Maruyama
Journal:  Lab Invest       Date:  2010-03-15       Impact factor: 5.662

2.  Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis.

Authors:  Hidehiro Sawa; Takashi Ueda; Yoshifumi Takeyama; Takeo Yasuda; Makoto Shinzeki; Takahiro Nakajima; Yoshikazu Kuroda
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

3.  Impact of serum high-mobility group box 1 protein elevation on oxygenation impairment after thoracic aortic aneurysm repair.

Authors:  Takashi Kohno; Toshihisa Anzai; Hideyuki Shimizu; Hidehiro Kaneko; Yasuo Sugano; Shingo Yamada; Tsutomu Yoshikawa; Akitoshi Ishizaka; Ryohei Yozu; Satoshi Ogawa
Journal:  Heart Vessels       Date:  2010-10-30       Impact factor: 2.037

4.  High-dose immunoglobulin preparations improve survival in a CLP-induced rat model of sepsis.

Authors:  Takahisa Yoshikawa; Hiroya Takeuchi; Koichi Suda; Taku Miyasho; Shingo Yamada; Minoru Okamoto; Yoshio Kawamura; Ikuro Maruyama; Masaki Kitajima; Yuko Kitagawa
Journal:  Langenbecks Arch Surg       Date:  2011-11-25       Impact factor: 3.445

5.  The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism.

Authors:  Kazuhiro Abeyama; David M Stern; Yuji Ito; Ko-ichi Kawahara; Yasushi Yoshimoto; Motoyuki Tanaka; Tomonori Uchimura; Nobuo Ida; Yoshiaki Yamazaki; Shingo Yamada; Yasuhiko Yamamoto; Hiroshi Yamamoto; Satoshi Iino; Noboru Taniguchi; Ikuro Maruyama
Journal:  J Clin Invest       Date:  2005-04-14       Impact factor: 14.808

6.  High-mobility group box 2 (HMGB2) modulates radioresponse and is downregulated by p53 in colorectal cancer cell.

Authors:  Young-Joo Shin; Mi-Sook Kim; Moon-Sun Kim; Joonseok Lee; Miae Kang; Jae-Hoon Jeong
Journal:  Cancer Biol Ther       Date:  2012-12-19       Impact factor: 4.742

7.  Functional roles for C5a receptors in sepsis.

Authors:  Daniel Rittirsch; Michael A Flierl; Brian A Nadeau; Danielle E Day; Markus Huber-Lang; Charles R Mackay; Firas S Zetoune; Norma P Gerard; Katherine Cianflone; Jörg Köhl; Craig Gerard; J Vidya Sarma; Peter A Ward
Journal:  Nat Med       Date:  2008-05-04       Impact factor: 53.440

8.  High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage.

Authors:  Takashi Nakahara; Ryosuke Tsuruta; Tadashi Kaneko; Susumu Yamashita; Motoki Fujita; Shunji Kasaoka; Teruto Hashiguchi; Michiyasu Suzuki; Ikuro Maruyama; Tsuyoshi Maekawa
Journal:  Neurocrit Care       Date:  2009-09-24       Impact factor: 3.210

9.  HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis.

Authors:  Sari Karlsson; Ville Pettilä; Jyrki Tenhunen; Raili Laru-Sompa; Marja Hynninen; Esko Ruokonen
Journal:  Intensive Care Med       Date:  2008-02-23       Impact factor: 17.440

10.  HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans.

Authors:  Erik D Peltz; Ernest E Moore; Phillip C Eckels; Sagar S Damle; Yuko Tsuruta; Jeffrey L Johnson; Angela Sauaia; Christopher C Silliman; Anirban Banerjee; Edward Abraham
Journal:  Shock       Date:  2009-07       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.